Showing results (1-10 of 1,561) with videos related to
Sort By:
Pageof 157
Experimental Hematology|January 1, 1985
Hematological toxicity: experience with anthracyclines and anthracenesG Falkson, B Klein, H FalksonCancer|April 15, 1985
Advanced ovarian carcinoma. Factors influencing survivalB Klein, G Falkson, C F SmitAmerican Journal of Clinical Oncology|December 1, 1990
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group studyG Falkson, A Cnaan, I W Simson, et al.Cancer Clinical Trials|January 1, 1981
Vindesine. A phase II trial in advanced breast cancer patientsH I Robins, D C Tormey, M J Skelley, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 1, 1986
Value of steroid hormone receptor analysis in predicting time to treatment failure in operable breast cancerB Klein, G Falkson, A P Terblanche, et al.Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 22, 1986
Granulocytic sarcoma of the kidney in a patient with acute myelomonocytic leukaemia. A case reportB Klein, G Falkson, I W Simson, et al.Cancer Treatment Reports|November 1, 1976
Phase II trial of cytembena in patients with advanced ovarian and breast cancerH C Falkson, G FalksonPageof 157